Yükleniyor... / Loading...
This study examined classifying older cancer patients according to their risk profile and personalizing interventions such as physical exercise. It enrolled patients aged 70 and older with a solid cancer who were candidates for systemic treatment. This study has no assigned phase and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * Patients aged 70 or over. * Solid cancer. * Candidates for systemic treatment (chemotherapy, hormone therapy, biological therapies or immunotherapy) if the time that has elapsed since the last dose of treatment has been at least 1 month (washout period). * Patients with breast, gynecological, lung, pleural, digestive, urological, ENT area, sarcomas, brain tumors, melanomas and patients with tumors of unknown origin will be included.Regarding tumor type and stage for patients with lymphoma: 1) Diffuse large B-cell NHL: include stages I-II if Bulky (\>7.5 cm) or R-IPI\>1. 2) Hodgkin lymphoma: stages I-II if Bulky (\>10 cm). 3) Follicular NHL and marginal NHL without GELF treatment criteria. 4) 80 years old receiving 6 R-mini CHOP cycles. Exclusion Criteria: * ECOG ≥3 * cases of advanced dementia * serious psychiatric illnesses * Lack of basic fluency in the Basque or Spanish language * those patients unable to get up from the chair and walk independently with or without auxiliary device. * Neither will those patients who participate in other studies in which they are undertaking a physical exercise program be included. * Absolute or relative contraindications in which the risk of adverse effects outweighs the possible benefits such as unstable angina, acute symptomatic heart failure ...